Background
Over the past two decades, data has emerged regarding the natural history of cervical intraepithelial neoplasia (CIN) in various age groups. Concomitant evidence showing obstetrical risk following treatment for CIN has led to the re-evaluation of guidelines for the management of abnormal cervical cancer screening tests and premalignant cervical disease with a trend towards conservative management. 1 However, surgical therapies remain the mainstay of treatment for high grade cervical intraepithelial neoplasia (CIN 2,3). Loop electrosurgical excision procedure (LEEP) is a commonly utilized diagnostic and treatment modality for CIN 2,3 because it provides a specimen for histological examination while being safe and effective in the outpatient setting. 2 In select patients, it also has the advantage of allowing diagnosis and treatment in a single visit. 2 Treatment is not without risk, however. As stated above, increased obstetrical risks following treatment with LEEP include preterm premature rupture of membranes, preterm delivery, and low birth weight.
3-5 Such risks highlight the trend for more conservative management of CIN 2 and CIN 2,3 especially in younger populations.
Women who have undergone treatment for CIN 2,3 are also at risk for persistent or recurrent disease, with rates of disease persistence/recurrence ranging from 2-48% following LEEP.
4,6-8 Such women are also at increased risk for developing invasive cervical cancer for as many as 20 years following treatment, further highlighting the need for follow-up in these patients. 
Results
Two hundred and twenty-eight women were identified who underwent LEEP for treatment of high grade cervical dysplasia at our institution from 1995 to 2006. Follow-up cytology was available for 167 of the women. The analysis was limited to 144 women for whom both documented LEEP margin status and cytological follow-up data were available.
The women were predominantly white, non-Hispanic, with a mean age of 27 years (range 14-62). Demographics for the women who underwent LEEP are presented (Table 1 ).
Similar to other reviews, current smoking status was associated with referral for treatment of cervical dysplasia (LEEP) (p=0.04).
Use of hormonal birth control (primarily combined oral contraceptives) approached significance for referral for treatment (p=0.06). Demographic variables were not associated with follow-up cytology results on univariate or multivariate analyses. The LEEP pathology reported positive margin status in 67 (47%) of the specimens and negative margin status in 77 (53%). For those specimens with a positive margin status where the involved margin was specified, the ectocervical margin was positive in 51 specimens and the endocervical margin was positive in 23 (this includes 7 specimens in which both the ecto-and endo-cervical margins were involved). The frequency of subsequent Pap smear results by margin status is presented in Table 2 . The mean depth of excision was 11.12 mm in those with normal cytology post-LEEP, 10.78 mm in those with a mild result, and 9.73 mm in those with a severe result. Using Wilcoxon rank sum test, there was no significant difference noted between mean depth of excision and follow-up cytology result (p =0.15).
Twenty-three women required subsequent colposcopy during the follow-up period: 7 with negative margin status and 16 with a positive margin status on their initial LEEP. The result of the follow-up colposcopy was not found to be significantly different based upon initial margin status (p=0.19), grade of dysplasia at the margin (p=0.33), or depth of excision (p=0.82). Additionally, multivariate analysis using the covariates listed above found no significant factors. However, when the sample was restricted to women who had a positive margin at initial treatment, the margin depth approached significance (p=0.06).
Discussion
The present study sought to evaluate the significance of a positive margin following treatment with LEEP as it relates to risk for future abnormal cytology. Although guidelines for the management of such patients exist, there is little data or consensus on whether these patients should be followed clinically or undergo reexcision. Furthermore, no data exists regarding adherence to the present recommendations following treatment.
In an attempt to determine the best course of action for such patients, many studies, including this one, have looked at risk factors for recurrence of cervical dysplasia to determine those patients for whom the risk of disease recurrence outweighs the risks of re-excision. While re-excision in patients with a positive margin is well tolerated and effective, 6, 10 there are risks associated with reexcision. Risks of repeat excision must be weighed against the potential risk of untreated CIN or the potential for a missed diagnosis of invasive carcinoma within an un-excised focus at the involved margin. This has become especially important in light of recent data showing increased obstetrical risks following LEEP and the desire to therefore limit cervical excision in women desiring future fertility. [3] [4] [5] In the present study, we were unable to identify risk factors to predict recurrent abnormal cytology related to LEEP margin status. Previous studies have reported conflicting results, with many studies showing a statistically higher rate of disease recurrence (as determined by follow-up cytology) in those with a positive LEEP resection margin. 8, [11] [12] [13] [14] [15] [16] [17] Margin status was compared in several studies, again with conflicting results: statistically higher rate of persistence/recurrence was seen only in those patients with involvement of the ectocervical margin 17 or endocervical margin 7, 12, 16 or only with extensive involvement of the margin. 13 Limitations of our study include the small sample size. This is largely a reflection of the referral population base and study methods. The majority of women who are referred to the University for evaluation of abnormal cervical cytology and treatment of cervical dysplasia are cared for by practitioners from a wide geographical area and tend to receive follow up care with their referring providers Thus, we do not have available post-LEEP cytology for all women. Another limitation was the transition of our clinic records from a paper record to an electronic medical record during the study period. Thus, some women who underwent LEEP did not have all the required information and were excluded. While our findings are limited, it is unlikely that our findings have been biased by the referral population or methods available. Our findings are similar to other studies in that noninvasive LEEP histology is a poor predictor of recurrent CIN following LEEP.
In conclusion, we were unable to identify which women are at risk for a recurrence of CIN following LEEP based on margin status. Thus, we recommend surveillance of all women who have undergone LEEP for treatment of CIN regardless of margin status.
